F.E.C. Calais Da Silva: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

High Dosage of Vitamin D Regulates the Energy Metabolism and Increases Insulin Sensitivity, but are Associated with High Levels of Kidney Damage

Gaspar, Rafael Calais, Botezelli, José Diego, Kuga, Gabriel Keine, Muñoz, Vitor Rosetto, Coope, Andressa, Pereira, Rodrigo Martins, da Silva, Adelino Sanchez Ramos, Cintra, Dennys Esper, de Moura, Lea

Journal:

Drug Development Research

Year:

2017

Language:

english

File:

PDF, 497 KB

english, 2017

2

Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients

Carraro, Jean-Christophe, Raynaud, Jean-Pierre, Koch, Gary, Chisholm, Geoffrey D., Di Silverio, Franco, Teillac, Pierre, Da Silva, Fernando Calais, Cauquil, Joris, Chopin, Dominique K., Hamdy, Freddie

Journal:

Year:

1996

Language:

english

File:

PDF, 926 KB

english, 1996

3

Evaluation of the Clinical Benefit of Permixon and Tamsulosin in Severe BPH Patients—PERMAL Study Subset Analysis

Frans Debruyne, Peter Boyle, Fernando Calais Da Silva, Jay G Gillenwater, Freddie C Hamdy, Paul Perrin, Pierre Teillac, Remigio Vela-Navarrete, Jean-Pierre Raynaud, Claude C Schulman

Journal:

European Urology

Year:

2004

Language:

english

File:

PDF, 141 KB

english, 2004

4

Intermittent Androgen Deprivation for Locally Advanced and Metastatic Prostate Cancer: Results from a Randomised Phase 3 Study of the South European Uroncological Group

Fernando E.C. Calais da Silva, Aldo V. Bono, Peter Whelan, Maurizio Brausi, Anton Marques Queimadelos, Jose A. Portillo Martin, Ziya Kirkali, Fernando M.V. Calais da Silva, Chris Robertson

Journal:

European Urology

Year:

2009

Language:

english

File:

PDF, 331 KB

english, 2009

5

Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?

Wolff, Johannes M., Abrahamsson, Per-Anders, Irani, Jacques, Calais da Silva, Fernando

Journal:

BJU International

Year:

2014

Language:

english

File:

PDF, 887 KB

english, 2014

6

Dithiothreitol-based protein equalization method: A powerful tool in bladder cancer biomarker discovery

Baltazar, P.M., Araújo, J.E., López-Fernández, H., Campos-Pinheiro, L., Calais-Da-Silva, F., Carrascal, M., Videira, P., Santos, H.M., Capelo-Martínez, J.L.

Journal:

European Urology Supplements

Year:

2017

Language:

english

File:

PDF, 72 KB

english, 2017

7

Quality of life in patients with prostatic cancer a feasibility study

F. Calais Da Silva, Elizabeth Reis, Telmo Costa, Louis Denis

Journal:

Year:

1993

Language:

english

File:

PDF, 478 KB

english, 1993

8

Quality of life in prostatic cancer patients

F. Da Calais Silva

Journal:

Year:

1993

Language:

english

File:

PDF, 367 KB

english, 1993

9

Large-scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial

Harry J. de Koning, Anssi Auvinen, Antonio Berenguer Sanchez, Fernando Calais da Silva, Stefano Ciatto, Louis Denis, John K. Gohagan, Matti Hakama, Jonas Hugosson, Ries Kranse, Vera Nelen, Philip C. P

Journal:

International Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 79 KB

english, 2002

10

Quality of life in prostate cancer

Dr Sophie D. Fosså, Stein Kaasa, Fernando Calais Da Silva, Stefan Suciu, Michiel W. Hengeveld

Journal:

Year:

1992

Language:

english

File:

PDF, 245 KB

english, 1992

11

Prophylactic antibiotherapy in urological surgery

F. Calais da Silva

Journal:

Year:

1992

Language:

english

File:

PDF, 517 KB

english, 1992

12

CURRENT METHODS OF ASSESSING AND TREATING CARCINOMA IN SITU OF THE BLADDER WITH OR WITHOUT INVOLVEMENT OF THE PROSTATIC URETHRA

KH Kurth (c), PF Schellhammer (cc), E Okajima (cc), A Akdas, G Jakse, HW Hen, F Calais da Silva, S Fukushima, T Nagayama

Journal:

International Journal of Urology

Year:

1995

Language:

english

File:

PDF, 1.53 MB

english, 1995

13

CURRENT METHODS OF ASSESSING AND TREATING CARCINOMA IN SITU OF THE BLADDER WITH OR WITHOUT INVOLVEMENT OF THE PROSTATIC URETHRA

KH Kurth (c), PF Schellhammer (cc), E. Okajima (cc), A. Akdas, G. Jakse, HW Hen, F Calais da Silva, S. Fukushima, T. Nagayama

Journal:

International Journal of Urology

Year:

1995

Language:

english

File:

PDF, 1.53 MB

english, 1995

14

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, Wolfgang Hoeltl, Fernando Calais Da Silva, Philip H. Powell, Stephen Prescott, Ziya Kirkali, Cees van de Beek, Thierry Gorlia, Theo M. de Reij

Journal:

European Urology

Year:

2010

Language:

english

File:

PDF, 408 KB

english, 2010

15

Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guérin and with Bacillus Calmette-Guérin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993)

Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, Fernando Calais da Silva, Christer Busch, Ferran Algaba, Sandra Collette, Aldo Bono

Journal:

European Urology

Year:

2011

Language:

english

File:

PDF, 328 KB

english, 2011

16

Comparison of a Phytotherapeutic Agent (Permixon) with an α-Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: A 1-Year Randomized International Study

Frans Debruyne, Gary Koch, Peter Boyle, Fernando Calais Da Silva, Jay G. Gillenwater, Freddie C. Hamdy, Paul Perrin, Pierre Teillac, Remigio Vela-Navarrete, Jean-Pierre Raynaud

Journal:

European Urology

Year:

2002

Language:

english

File:

PDF, 4.30 MB

english, 2002

17

European School of Oncology Advisory report to the European Commission for the “Europe Against Cancer Programme” European Code Against Cancer

P. Boyle, U. Veronesi, M. Tubiana, F.E. Alexander, F.Calais da Silva, L.J. Denis, J.M. Freire, M. Hakama, A. Hirsch, R. Kroes, C. La Vecchia, P. Maisonneuve, J.M. Martin-Moreno, J. Newton-Bishop, J.J.

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 1.57 MB

english, 1995

18

615 - Comparative study of intravesical instillation of epirubicin, BCG, or BCG + INH in intermediate and high risk pTa-pT1 papillary carcinoma of the urinary bladder. First results of EORTC 30911

A.v.d. Meijden, M. Brausi, W. Höltl, D. Mack, R.v. Velthoven, F. Calais da Silva, R. Sylvester, C. de Balincourt

Journal:

European Journal of Cancer

Year:

1997

Language:

english

File:

PDF, 255 KB

english, 1997

19

Updated concepts and treatment of carcinoma in situ

Donald Lamm, Harry Herr, Gerhard Jakse, Masao Kuroda, F.Kash Mostofi, Eigoro Okajima, Atsuhiko Sakamoto, Isabell Sesterhenn, Fernando Calais da Silva

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

1998

Language:

english

File:

PDF, 70 KB

english, 1998

20

Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility

Teixeira, A L, Ribeiro, R, Morais, A, Lobo, F, Fraga, A, Pina, F, Calais-da-Silva, F M, Calais-da-Silva, F E, Medeiros, R

Journal:

The Pharmacogenomics Journal

Year:

2009

Language:

english

File:

PDF, 150 KB

english, 2009

21

776 POOLED ANALYSIS OF TWO PROTOCOLS OF INTERMITTENT HORMONAL THERAPY IN ADVANCED PROSTATIC CANCER

Calais da Silva, Fernando M., Brausi, Maurizio, Gonçalves, Frederico, Kliment, Jan, Queimadelos, Antonio, Calais da Silva, Fernando E., Robertson, Chris

Journal:

The Journal of Urology

Year:

2012

Language:

english

File:

PDF, 50 KB

english, 2012

22

509 POSTER Epidermal growth factor (EGF) +61 A/G functional genetic polymorphism influences disease-free interval in androgen blockade treated prostate cancer patients

A.L. Teixeira, R. Ribeiro, D. Cardoso, D. Pinto, A. Morais, F. Lobo, F.M. Calais-da-Silva, F.E. Calais-da-Silva, R. Medeiros

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 68 KB

english, 2007

23

536 POSTER Apoptosis in Bladder and prostate cancer: The role of FAS and FASL polymorphisms

L. Lima, A. Morais, F. Lobo, F.M. Calais-da-Silva, F.E. Calais-da-Silva, L. Santos, R. Medeiros

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 65 KB

english, 2007

24

1152 POSTER STARS – surveillance on the treatment of anaemia: a retrospective survey

F. Nogueira, F. Calais, J. Leal da Silva, J. Espírito Santo, B. Polo, J.P. Duarte, A. Plácido, D. Silva, L. Arez, P. Pinto

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 63 KB

english, 2007

25

Gemcitabine plus cisplatin, a modifed regimen in advanced urothelial cancer: A phase II trial

F.M. Calais da Silva

Journal:

European Urology Supplements

Year:

2003

Language:

english

File:

PDF, 189 KB

english, 2003

26

Phase III study of intermittent MAB versus continuous MAB international cooperative study

F. Calais da Silva, A. Bono, P. Whelan, M. Brausi, M. Queimadelos, P. Martin, Z. Kirkali, C. Robertson

Journal:

European Urology Supplements

Year:

2003

Language:

english

File:

PDF, 237 KB

english, 2003

27

349 Evaluation of the clinical benefit of Permixon and Tamsulosin in severe BPH patients. Permal study sub-set analysis

F. Debruyne, P. Boyle, F. Calais da Silva, R. Vela Navarrete, F. Hamdy, P. Teillac, P. Perrin, J.P. Raynaud

Journal:

European Urology Supplements

Year:

2004

Language:

english

File:

PDF, 198 KB

english, 2004

28

568Phase 2 protocol with docetaxel plus prednisone in patients with hormone refractory prostate cancer

F.M. Calais da Silva, F.E. Calais da Silva

Journal:

European Urology Supplements

Year:

2005

Language:

english

File:

PDF, 194 KB

english, 2005

29

902Phase 3 study of intermittent mab versus continuous mab international cooperative study

F.E. Calais da Silva, A. Bono, P. Whelan, M. Brausio, M. Queimadelos, J. Portilho, Z. Kirkah, F.M. Calais da Silva, C. Robertson

Journal:

European Urology Supplements

Year:

2005

Language:

english

File:

PDF, 197 KB

english, 2005

30

903Phase 3 study intermittent monotherapy versus continuous combined androgen deprivation an international cooperative study

F.E. Calais da Silva, F. Gonsalves, A. Santos, J. Kliment, F.M. Calais da Silva, S. Pastidis, M. Queimadelos, C. Robertson

Journal:

European Urology Supplements

Year:

2005

Language:

english

File:

PDF, 197 KB

english, 2005

31

877Phase 2 study 2000mg of intravesical gemcitabine in marker lesions

F.M. Calais da Silva, F.E. Calais da Silva

Journal:

European Urology Supplements

Year:

2005

Language:

english

File:

PDF, 166 KB

english, 2005

32

PHASE II STUDY OF INTRAVENOUS VINORELBINE PLUS HORMONE THERAPY IN HORMONE-REFRACTORY PROSTATE CANCER

F. Calais Da Silva Junior, F.E. Calais Da Silva

Journal:

European Urology Supplements

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

33

PHASE II SCREENING STUDY TO ASSESS THE COMBINATION OF AN LHRH ANALOGUE, DEXAMETHASONE AND SOMATOSTATIN ANALOGUE VERSUS LHRH ANALOGUE WITH DEXAMETHASONE IN HORMONE-REFRACTORY PROSTATE CANCER PATIENTS

F. Calais da Silva junior, F. Calais Da Silva, T. Oliver, F. Gonçalves

Journal:

European Urology Supplements

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

34

Interleukin-6 functional polymorphism influences susceptibility and has a predictive factor in prostate cancer patients receiving androgen blockade therapy

A. Azevedo, R. Ribeiro, A. Fraga, F. Pina, F. Lobo, A. Morais, F.E. Calais da Silva, F.M. Calais da Silva, R. Medeiros

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 84 KB

english, 2008

35

Proliferative/Angiogenic genetic profile is associated with progression-free-interval in androgen blockade treated prostate cancer patients

A.L. Teixeira, R. Ribeiro, A. Morais, F. Lobo, A. Fraga, F.M. Calais-da-Silva, F.E. Calais-da-Silva, F. Pina, R. Medeiros

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 90 KB

english, 2008

36

1101 Prostate cancer and apoptosis: An insight of FAS-670A/G polymorphism role in tumor development

L. Lima, A.M. Gomes, R. Ribeiro, A. Fraga, F. Pina, F. Lobo, F. Calais-da-Silva, R. Medeiros

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 49 KB

english, 2009

37

97 Non-synonym leptin receptor genetic variants, prostate cancer susceptibility and aggressiveness

C. Monteiro, R. Ribeiro, A. Azevedo, V. Cunha, A. Fraga, F. Pina, F. Calais da Silva, F. Lobo, R. Medeiros

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 67 KB

english, 2010

38

96 Adiponectin functional polymorphisms and haplotype are associated with prostate cancer aggressiveness and to hormonal castration resistance

V. Cunha, R. Ribeiro, A. Azevedo, C. Monteiro, F. Pina, A. Fraga, F. Calais da Silva, F. Lobo, R. Medeiros

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 48 KB

english, 2010

39

89 Influence of functional genetic variants of TGFβ1/TGFβR2 pathway in prostate cancer development

A.L. Teixeira, R. Ribeiro, M. Gomes, C. Pereira, F. Lobo, A. Fraga, F. Calais-da-Silva, F. Pina, R. Medeiros

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 70 KB

english, 2010

40

380 Combined analysis of SNPs in IL-6/IL-6R pathway predict prostate cancer aggressiveness and development of resistance to hormonal castration

A. Azevedo, R. Ribeiro, V. Cunha, C. Monteiro, F. Pina, A. Fraga, F. Calais da Silva, F. Lobo, R.U.I. Medeiros

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 49 KB

english, 2010

41

22 PHASE III STUDY OF INTERMITTENT MONOTHERAPY VERSUS CONTINUOUS COMBINED ANDROGEN DEPRIVATION

F.E. Calais Da Siva, F.M. Calais Da Silva, F. Gonçalves, A. Santos, J. Kliment, N. Antoniou, S. Pastidis

Journal:

European Urology Supplements

Year:

2007

Language:

english

File:

PDF, 319 KB

english, 2007

42

154 CYTOKINE GENE POLYMORPHISMS: INFLUENCE IN THE RESPONSE OF BLADDER SUPERFICIAL CARCINOMA TO THE IMMUNOTHERAPEUTIC TREATMENT WITH BCG

F.M. Calais Da Silva, F.E. Calais Da Silva, D. Ligeiro, J. Sobral, H. Trindade

Journal:

European Urology Supplements

Year:

2007

Language:

english

File:

PDF, 318 KB

english, 2007

43

673 THE RELATIONSHIP BETWEEN BIOCHEMICAL FAILURE AND TP53 GENETIC POLYMORPHISM IN PATIENT WITH PROSTATE CANCER

F.M. Calais Da Silva, H. Sousa, A. Coelho, F.E. Calais Da Silva, R. Medeiros

Journal:

European Urology Supplements

Year:

2007

Language:

english

File:

PDF, 315 KB

english, 2007

44

PROGNOSTIC FACTORS IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE TA T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE EPIRUBICIN OR MAINTENANCE BACILLUS CALMETTE-GUERIN. RESULTS OF EORTC GU GROUP STUDY 30911

R.J. Sylvester, W. Oosterlinck, M.A. Brausi, W.J. Kirkels, F. Calais Da Silva, T. Gorlia, Z. Kirkali

Journal:

European Urology Supplements

Year:

2008

Language:

english

File:

PDF, 70 KB

english, 2008

45

ZOLEDRONIC ACID IN M1 PATIENTS: HRPC VS. HORMONAL SENSITIVE

F.M. Calais Da Silva, F.E. Calais Da Silva

Journal:

European Urology Supplements

Year:

2008

Language:

english

File:

PDF, 72 KB

english, 2008

46

EVALUATION OF QUALITY OF LIFE, SIDE EFFECTS AND DURATION OF THERAPY IN A PHASE 3 STUDY OF INTERMITTENT MONOTHERAPY VERSUS CONTINUOUS COMBINED ANDROGEN DEPRIVATION

F.E. Calais Da Silva, F. Goncalves, A. Santos, J. Kliment, F.M. Calais Da Silva, P. Whelan, T. Oliver, N. Antoniou, S. Pastidis, A. Queimadelos, C. Robertson

Journal:

European Urology Supplements

Year:

2008

Language:

english

File:

PDF, 73 KB

english, 2008

47

142 PHASE III STUDY OF INTERMITTENT MONOTHERAPY VERSUS CONTINUOUS COMBINED ANDROGEN DEPRIVATION

F. Calais Da Silva Junior, F.E.C. Calais Da Silva, F.E.C. Gongalves, A.R. Santos, J.K. Kliment, P. Whelan, T. Oliver, N. Antoniou, S. Pastidis, A.M. Queimadelos

Journal:

European Urology Supplements

Year:

2010

File:

PDF, 98 KB

2010

48

189 SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH MITOMYCIN C (MMC) AND BACILLUS CALMETTE-GUERIN (BCG) VERSUS BCG ALONE IN PATIENTS WITH CARCINOMA IN SITU (CIS) OF THE URINARY BLADDER. RESULTS OF EORTC GU GROUP RANDOMIZED PHASE II STUDY 30993

W. Oosterlinck, Z. Kirkali, R.J. Sylvester, F. Calais Da Silva, C. Busch, F. Algaba, S. Collette, A.V. Bono

Journal:

European Urology Supplements

Year:

2010

File:

PDF, 83 KB

2010

49

900 PHASE II STUDY OF A COMBINATION OF A LHRH ANALOGUE, DEZAMETHASONE AND A SOMATOSTATIN ANALOGUE (SM-A) VERSUS A LHRH ANALOGUE WITH DEXAMETHASONE IN REFRACTORY PROSTATE CANCER PATIENTS

F. Calais Da Silva Junior, F.E. Calais Da Silva, T. Oliver, G. Frederico

Journal:

European Urology Supplements

Year:

2010

File:

PDF, 83 KB

2010

50

800 PHASE II STUDY OF INTERMITTENT MAB VS. CONTINUOUS MAB

F.M. Calais Da Silva Junior, A. Bono, P. Whelan, M. Brausi, A. Queimadelos, J. Portillo, Z. Kirkali, F. Calais Da Silva Senior

Journal:

European Urology Supplements

Year:

2011

Language:

english

File:

PDF, 221 KB

english, 2011

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски